Safetraces
safetraces.com
Actively hiring
Biotechnology
Real Estate
Diagnostic Tests & IVD
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$19M
10 rounds on record
Latest round
$10M
Venture round · Sep 2018 · 8 yr ago
Team
51-200
employees, estimated range
Grants
$4.3M
8 grants · CORDIS
Backers
1
S2G Investments
The money's age
Long since its last round
96 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 22, 2018
New executive Antonios Zografos, Executive Officer, Director · SEC Form D
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Grant | Sep 2025 | $1.3M | — | CORDIS |
| Grant | May 2023 | $74k | — | CORDIS |
| Grant | Nov 2022 | $74k | — | CORDIS |
| Grant | Jul 2022 | $749k | — | CORDIS |
| Grant | Nov 2021 | $49k | — | CORDIS |
| Venture round | Sep 2018 | $10M | — | SEC Form D |
| Grant | Sep 2018 | $981k | — | CORDIS |
| Grant | Sep 2017 | $959k | — | CORDIS |
| Venture round | Sep 2017 | $9M | — | SEC Form D |
| Grant | Sep 2016 | $140k | — | CORDIS |
Registers and programsofficial lists and records that name the company
| Legal entity | SafeTraces, Inc. | its site |
Founders and leadersfrom filings, registers and the company's site
Anthony ZografosExecutive Officer, DirectorSEC Form D
Ulrike HodgesDirectorSEC Form D
Antonios ZografosExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
S2G Investments Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Diagnostic simplicity in every moment. For everyone. Solios offers integrated platforms for point of care rapid diagnostic tests…
Loop Diagnostics is a biotech company that develops a diagnostic tool for sepsis, using an in vitro cellular immunoassay to detect it…
Nanopath has developed deep technological breakthroughs that have the potential to change the molecular diagnostic paradigm.
Scanbase makes it easy to convert photos of rapid diagnostic tests into positive or negative results.
ScopeDx: Transforming molecular diagnostics with CRISPR-Cas.
Llusern Scientific is a UK diagnostics company developing treatment-directing diagnostics that bring rapid molecular testing closer to the…
People
Anthony Zografos
Executive Officer, Director
Ulrike Hodges
Director
Antonios Zografos
Executive Officer, Director
Elliott Grant
Director
John Kraus
Director
Rob Veres
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Pleasanton
United States
HQ
50-200 est. staff
Financials
Total raised
$23.3M
Latest round
Grant
Funding rounds
10
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Grant | 2025 | $1.3M | Details |
| Grant | 2023 | $74k | Details |
| Grant | 2022 | $74k | Details |
| Grant | 2022 | $749k | Details |
| Grant | 2021 | $49k | Details |
| Venture - Series Unknown | 2018 | $10M | Details |
| Grant | 2018 | $981k | Details |
| Grant | 2017 | $959k | Details |
| Venture - Series Unknown | 2017 | $9M | Details |
| Grant | 2016 | $140k | Details |